TFGT
SUPN icon

TS Financial Group (TSFG)’s Supernus Pharmaceuticals SUPN Stock Holding History

TS Financial Group (TSFG)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31
Closed -$1K – 856
2019
Q4 		$1K Hold
31
– – ﹤0.01% 775
2019
Q3 		$1K Hold
31
– – ﹤0.01% 759
2019
Q2 		$1K Buy
+31
New +$1.06K ﹤0.01% 732

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TS Financial Group (TSFG)'s SUPN Position: Q1 2020 in Review

TS Financial Group (TSFG) sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 31 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in SUPN in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • TS Financial Group (TSFG) reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 31 Supernus Pharmaceuticals shares in Q1 2020, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Supernus Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • TS Financial Group (TSFG)'s Supernus Pharmaceuticals position peaked at $1K in Q4 2019.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2020, filed 8 Apr 2020.